Valuation Abbott Laboratories Swiss Exchange

Stocks

Market Closed - Swiss Exchange 09:05:38 27/08/2026 pm IST			5-day change	1st Jan Change
90.50 ^CHF	-2.69%		-2.69%	-8.59%

28/08	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
27/08	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,41,365	1,91,427	1,91,088	1,96,184	2,17,859	1,94,616	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-10.67%	-	-
Enterprise Value (EV) ¹	2,49,166	1,98,318	1,98,871	2,02,693	2,22,266	2,18,555	2,15,573	2,11,883
Change	-	-20.41%	0.28%	1.92%	9.66%	-1.67%	-1.36%	-1.71%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	32.3x	24.9x	22.2x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	4.06x	3.89x	3.69x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.14x	0.8x	1.8x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.87x	3.56x	3.33x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.34x	3.94x	3.63x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	16.7x	14.8x	13.2x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	18.6x	16.6x	14.8x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	27.6x	23x	20.7x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.63%	4.34%	4.82%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.571	2.741	2.896
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.29%	2.44%	2.57%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.486	4.524	5.074
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	73.7%	60.6%	57.1%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,302	54,646	58,409
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	13,090	14,598	16,020
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,719	13,021	14,313
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,232	7,924	8,850
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	112.47	112.47	112.47
Nbr of stocks (in thousands)	17,14,968	17,43,574	17,36,059	17,34,455	17,38,834	17,30,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	32.26x	4.34x	16.7x	2.29%	19TCr
MEDTRONIC PLC	20.54x	3.56x	12.55x	3.26%	12TCr
CENCORA, INC.	17.63x	0.2x	12.88x	0.74%	6.15TCr
BECTON, DICKINSON AND COMPANY	36.52x	3.5x	12x	2.07%	5.16TCr
HOYA CORPORATION	29.92x	7.37x	19.04x	1.34%	5.1TCr
DEXCOM, INC.	36.41x	6.41x	20.12x	-.--%	3.43TCr
MEDLINE INC.	46.31x	1.31x	12.01x	0.16%	3.1TCr
WEST PHARMACEUTICAL SERVICES, INC.	39.35x	6.89x	24.72x	0.27%	2.37TCr
TERUMO CORPORATION	19.61x	3.03x	11.04x	1.46%	2.34TCr
Average	30.95x	4.07x	15.67x	1.29%	6.53TCr
Weighted average by Cap.	29.34x	3.95x	15.32x	1.86%